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research, which was concerned with the stability constants 
of divalent metal ions with various ligands. They seemed to 
form a series: Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+. 
As was then customary in the USA, but not in the UK, 
Pauling asked a question of the speaker during the lecture, 
who said that he would answer the enquiry after the lec-
ture. When Pauling asked the Chairman, “Who was that 
post-doctoral student who was speaking?” he was told that 
he wasn’t a post-doc, not even a graduate student, but still 
an undergraduate! The order of the ions became known [1] 
as the Irving-Williams series.
R. J. P. Williams or, as he was always known, Bob Wil-
liams, was a man who enjoyed thinking (Fig. 1). Not neces-
sarily with some action in mind, but the very act of cogita-
tion gave him pleasure. In a very perceptive review [2] in 
1953 entitled “Metal ions in biological systems,” he consid-
ered the whole subject of metal complexes, including their 
role in catalysis and especially enzyme activity. It is amaz-
ing how perceptive the conclusions are to this article:
 1. Metal enzymes and other metal compounds of biolog-
ical interest are divided into two groups. One group 
contains a specific activating metal ion, whereas the 
other class of compounds, which is composed of 
enzymes only, requires a metal ion as a catalyst, sev-
eral metal ions being somewhat differently active.
 2. The formation of complexes between metal ions and 
simple ligands is a useful model for the formation of 
compounds between substrates, prosthetic groups, 
and the same metal ions.
 3. Reasons are given for thinking that the stability of 
metal complexes usually falls into a fixed order of the 
metal ions such that.
   MnII < FeII < CoII < NiII < CuII > ZnII
  and
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  BaII < SrII < CaII < MgII
  These orders are largely independent of the ligand.
 4. However, certain metal ions can interact in a spe-
cific manner with special ligands. In particular, 
ferrous iron reacts strongly with aromatic nitrogen 
bases.
 5. In a system in which there is an excess of ligands 
over metal ions and in which many different types of 
ligand are present, the different metal ions will not be 
found in the same kinds of complexes. It is suggested 
that a body fluid is such a system.
 6. The formation of the different complexes of the metal 
ions is further restricted by the specific reactions men-
tioned in 4 above.
 7. In a biological fluid the pH is fixed, and this pH will 
also limit the types of complexes that the various 
metal ions can form. The hydrogen ion is to be con-
sidered a competing metal ion and the hydroxyl ion a 
competing ligand.
 8. The catalytic activity of metal ions in acid–base 
hydrolyses is interpreted in terms of intermediate 
complex formation. The mechanism of some of these 
reactions is discussed, as the reactions are very simi-
lar to certain enzyme reactions.
 9. The interaction of metal ions with proteins is not 
very different from their interaction with simpler sub-
stances, but the large number of different coordinating 
groups available in a protein makes the interpretation 
of results difficult.
 10. In proteins, some metals only occur in combination 
with certain co-ordinating groups; iron only occurs in 
the porphyrin nucleus.
 11. The oxidation–reduction potentials of the haem pro-
teins are discussed in the light of our knowledge of 
the potentials in model systems. The ferric haems are 
compared with chlorophyll.
 12. The copper enzymes, such as haemocyanin, would 
appear to involve combination of the metal sulphur 
groups.
 13. The specific interaction between phenolic or enolic 
groups and cupric ions is examined and an explana-
tion of their importance is suggested in terms of the 
model systems.
 14. The specific requirements for zinc and cobaltic ions 
are not understood, and only tentative suggestions can 
be made as to the nature of their compounds.
 15. The less specific metal ion requirements of pepti-
dases, phosphatases and carboxylases are discussed in 
terms of the models. The existing theories describing 
the function of the metal ions are criticized, and cer-
tain suggestions are made as to the importance of the 
different types of complexes formed by the different 
metal ions.
Items 10–12 in this list are wrong, but this is not unex-
pected given how little was known at the time about, e.g., 
redox-active proteins and enzymes containing iron-sulfur 
centres, but it is a surprisingly perceptive article, especially 
since it was created so soon after Bob became a regular 
inorganic chemist. He was given advice by many people to 
avoid an interest in matters related to biology; fortunately, 
he ignored this.
Vitamin B12
After she had determined the crystal structure of penicil-
lin [3], Dorothy Hodgkin tackled [4] that of Vitamin B12, 
and concomitantly Bob set about acquiring the physico-
chemical data. It was relatively easy, owing to the intense 
absorption of the corrin, to study by electronic absorption 
spectroscopy, but other properties were more difficult to 
Fig. 1  Some areas of research 
in which R. J. P. Williams made 
significant contributions, both 
experimental and theoretical
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study. Nevertheless, the oxidation states of aquocobalamin 
and its reduced forms were determined [5] electrochemi-
cally as +3, +2, and +1. Though large amounts of rela-
tively standard physical studies were published, the authors 
were particularly intrigued by the novel forms containing 
a Co–C bond, especially the coenzyme B12 and methylco-
balamin. Thus these forms could be described as alkylated 
derivatives. But how were the coenzymes involved in the 
enzymatic reactions? Of course, it was obvious that when 
either coenzyme bound to an apoenyzme giving the vari-
ous holoenzymes and in the presence of the appropriate 
substrate, the Co–C bond would transiently break–but the 
question was how?
One of the physical methods that had been used was 
electron paramagnetic resonance (EPR) spectroscopy [6], 
valuable for the low-spin d7 cobalt(II) derivatives. It was 
quite a surprise to find, in the holoenzyme diol-dehydratase, 
the system gave rise [7] to a striking EPR spectrum in the 
presence of the substrate that was not obviously related to 
that of an unaltered Co(II) form. Instead, it seemed more 
sensible to derive it from a Co(II) derivative of the corri-
noid and the deoxyadenosyl fragment. Since that very early 
result, similar conclusions have been reached about many 
other B12-dependent enzymes.
The ability to investigate such systems has advanced 
nearly beyond measure with developments in genetic 
engineering, the sensitivity of EPR spectrometers, and, 
strangely enough, the advances in theoretical methods. 
For example, Jensen and Ryde performed [7] an inter-
esting treatment of glutamate mutase and found that the 
bond dissociation energy of the Co–C bond is reduced by 
135 kJ/mol in the enzyme, the effect owing to four terms: 
the restriction of the adenosyl radical to 4.2 Å of the Co 
ion, and the dissociated state is stabilised by 42 kJ/mol by 
electrostatic and van der Waals interactions. The other two 
terms come from the stabilization of the protein itself and 
of the remainder of the coenzyme. This information would 
have been immensely valuable to those considering the 
usefulness of another topic introduced by Bob, with his 
long-time colleague, Bert Vallee: entasis.
The entatic state
It was dithizone that brought Bob and Bert together in the 
1950s. Bob had used it as a reagent for metal ions in his 
investigation that ultimately resulted in the Irving-Williams 
series; Bert had found [8] it invaluable in his work on zinc-
containing enzymes, which at the time were represented by 
two examples, carbonic anhydrase and carboxypeptidase. 
When they eventually met, they found they had many inter-
ests in common, but they approached any situation from 
quite different stances. Bob was a man driven by ideas, 
Bert was concerned with action, though his training as an 
analyst was of great value in the investigation of these met-
alloenzymes. Over the years, more and more such enzymes 
were isolated, but the subject moved faster in the case of 
haem enzymes since they were, along with haem proteins, 
greatly aided by their ready availability and, in many cases, 
by their intense colours. Fortunately, in the case of the 
zinc(II) enzymes, replacement by cobalt(II) gave rise to a 
Co(II) enzyme that was usually quite active. Bob had loved 
making lists of the properties of metal complexes since the 
1950s and so, when he was on sabbatical leave with Bert, 
they presumably together made comparisons of the known 
metalloproteins and metalloenzymes with the properties of 
“model” complexes. The differences were great, so they 
proposed that in the biological complexes, the activity was 
associated with distortions, and they termed [9] the effect 
as being due to “entasis”; thus the protein or enzyme was 
in an entatic state. When more data become available, Bob 
returned [10] to the topic and gave a more convincing dis-
play of how proteins and enzymes exhibited conditions best 
described as entasis.
There has been some confusion over the meanings of 
entasis and a rack [11], and they are often treated as syn-
onymous. That is not true. Entasis refers to a static locally 
energised condition of a group, a state; whilst a rack refers 
to a particular stretching machinery for a mechanically 
induced change of state of both protein and group inter-
actions. An interesting paper [12] on “Recent advances in 
understanding blue copper proteins” attempts an explana-
tion of “unusual” spectroscopic features such as the intense 
absorption band around 600 nm or an EPR spectrum show-
ing a “weak” interaction between the unpaired electron and 
the nuclear moment of the copper(II). These were said to 
be associated with the presence of entasis or were rack-
induced, both because of the imposition of an unusual geo-
metric and electronic structure on the metal ion, thereby 
activating it.
A change of scenery
Bob and HAOH belonged to the so-called Oxford Enzyme 
Group (OEG), which gave local scientists freedom to do 
interdisciplinary research. Most of the interest centred on 
X-ray diffraction, since that had recently been achieved 
with the structure of lysozyme [13], and on the NMR of 
proteins, since it was felt that this would eventually add 
some information on the movement within proteins. Bob 
decided to investigate a range of cytochromes [14]; I stud-
ied copper proteins [15]. At one of the informative meet-
ings of the OEG, I asked a visiting lecturer, who had talked 
about electron transfer, about the electrochemistry of 
redox proteins. On hearing that this had not been reliably 
8 J Biol Inorg Chem (2016) 21:5–12
1 3
achieved, I decided to try. Eventually, with a young student, 
I succeeded [16], and so the field of protein electrochemis-
try was born.
The electrochemistry of enzymes was more difficult to 
achieve. Previously, seeking to make some use of the com-
bination of electrochemistry and enzymes [17], Hill and 
colleagues had eventually found that the combination of a 
ferrocene and glucose oxidase provided an excellent elec-
trochemical array to determine glucose. That it worked in 
whole blood [18], allowed the determination of glucose on 
a simple strip [19]. By 2013, over 25 billion such strips had 
been used. It is difficult to select the factors responsible for 
such success: the initial observation, the realisation that it 
could be the basis of a useful product, the search for proper, 
particularly financial, support, and the determination of 
those who sought to bring the product to the market place.
Supramolecular chemistry
Bob’s interest in understanding the recognition of substrates 
by haem proteins led us to consider in the later 1960s the 
effects of weak non-covalent forces between molecules, in 
so-called charge-transfer and Mulliken complexes. This was 
“supramolecular chemistry” long before that phrase was 
coined. It led to the use of paramagnetic centres as probes 
for the determination of solution structures by NMR spec-
troscopy, initially using low-spin Co(II) in porphyrins [20, 
21], and soon followed by the more general use of paramag-
netic lanthanide ions for protein structure determination.
Bob’s studies on the relaxation properties of a variety of 
chelated gadolinium complexes [e.g., 22] inspired me (PJS) 
to investigate the potential uses of Gd(DTPA) derivatives 
of polysaccharides as contrast agents for magnetic reso-
nance imaging (MRI) [23]. These were quite effective and 
attracted commercial interest from Amersham International 
and subsequently Guerbet.
Platinum anticancer drugs
Bob played an important role in initiating the development 
of platinum anticancer drugs. The anticancer activity of the 
cisplatin family of drugs was discovered in the laboratory 
of Barnett Rosenberg at Michigan State University in the 
late 1960s [24]. Rosenberg had discovered some interest-
ing effects of electrolysis products from Pt electrodes on 
the growth of bacteria [25], but Barney was a physicist and 
needed help to understand their mechanism of action and to 
elaborate on structure–activity relationships. In Bob’s own 
words, “Barney (Rosenberg) rang me up and said, ‘Bob, I 
am in difficulty, I don’t understand much about platinum 
chemistry. Will you be my consultant?’” [26].
The idea of using an inorganic compound, and especially 
a heavy metal complex, in therapy was not well-received by 
many people at that time, but Bob was always keen to promote 
and explore new ideas:“The first open [international] platinum 
meeting was run in Oxford in 1973, and basically I organized it 
at Wadham College and in the inorganic chemistry laboratory, 
which is totally appropriate, as cisplatin is inorganic” [26].
Bob corresponded with Rosenberg about the coordina-
tion chemistry of platinum. This played an important role 
in establishing a molecular basis for the effects Rosenberg 
observed. He had met Rosenberg earlier in the 1960s at a 
conference in California dealing with bioelectrochemistry 
and electron transfer, topics in which they shared a com-
mon interest. Bob’s DPhil student Andrew Thomson sub-
sequently spent 2 years (September 1965 to August 1967) 
in Rosenberg’s lab synthesising, characterizing and testing 
platinum complexes for antibacterial and anticancer activ-
ity [27], and initiated work on cisplatin itself [26].
In particular they noted the high strength and rela-
tive inertness of the Pt-NH3 bonds compared to the Pt–Cl 
bonds, which could readily undergo aquation. Such an acti-
vation mechanism is thought to be the key step in the bind-
ing of cisplatin to DNA in cells. The chloride concentra-
tion outside cells is high (ca. 104 mM) and decreases in the 
cytoplasm (ca. 25 mM) and is even lower in the nucleus 
(ca. 4 mM) where activation by hydrolysis is favoured. 
There is good evidence that platination of adjacent gua-
nines on DNA by the robust cis-{Pt(NH3)2}
2+ unit to pro-
duce an intrastrand GG crosslink distorts the DNA, leading 
to HMG protein binding and the initiation of cell death by 
apoptosis (programmed cell death) [28].
Cisplatin has been joined in the clinic by carboplatin, a 
much less reactive complex with a chelated dicarboxylate 
ligand (CBDCA) replacing the two chloride ligands, and by 
oxaliplatin, in which the amine N ligands are now part of 
a chelate ring (1,2-diaminocyclohexane, DACH) and oxa-
late is also chelated. Release of CBDCA from carboplatin 
in cancer cells can lead to similar DNA lesions as cisplatin, 
whereas in the case of oxaliplatin, protein recognition of 
{Pt(DACH)}2+ is different from cis-{Pt(NH3)2}
2+ and so 
lowers cross-resistance.
This early work showed that the trans isomer transplatin 
is inactive as an anticancer agent, and trans diamine com-
plexes were not further explored until relatively recently 
when some trans complexes have been found to have good 
activity [29]. Interestingly in our (PJS) lab we find that 
photoactivated trans diamine Pt(IV) prodrugs are more 
active than the cis analogues [30].
The NH3 ligands in cisplatin can be labilised when the 
Pt-NH3 bonds are trans to ligands with high trans effects, 
such as the sulfur ligands in the amino acids methionine 
(thioether) and cysteine (thiol) [31]. Consequently the 
molecular pharmacology of cisplatin is more complicated 
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than originally believed. Interactions of cisplatin with 
the copper influx transporter Ctr1, copper chaperone 
Atox1, and copper pumps ATP7A and ATP7B appear to 
be involved with Pt transport in cells and involve bind-
ing to methionine and cysteine residues. Further studies 
of such interactions may lead to a better understanding of 
the side-effects of Pt drugs and of resistance [32]. [Pt(l-
methionine)2] is a metabolite of cisplatin [33].
Organometallic anticancer complexes
Bob’s early interest in platinum drugs led me (PJS) to 
explore the broader area of transition metal anticancer com-
plexes and their mechanisms of action. Initially we focussed 
on DNA as the target, since this is effective for cisplatin, but 
we attempted to create DNA lesions that were structurally 
distinct for those of platinum drugs, in the hope of circum-
venting cross-resistance (currently a clinical problem).
Our organometallic half-sandwich “piano-stool” Ru(II) 
complexes formed monofunctional as distinct from bifunc-
tional (chelated) lesions on DNA formed by cisplatin and were 
not cross-resistant [34]. Our approach has kept in mind the 
principles that were prominent in Bob’s thinking: the need to 
consider not only the thermodynamics (equilibria) that might 
be involved in reactions with biomolecules (targets), but also 
the kinetics (rates of ligand exchange) as well as both metal 
and ligand-based redox reactions. He also stressed that reac-
tions in cells seldom reach equilibrium. Although it is often 
useful to study “model” reactions in order to gain insight into 
biological mechanisms of action, we need to remember that 
cells are systems, rather than a collection of unconnected bio-
molecules. The biological system often functions under con-
ditions far from equilibrium. Pumps, transporters, feedback 
loops, and other pathways often determine the flux of avail-
able ligands and electrons. To understand the mechanism of 
action of metallodrugs, many of which are multi-targeted, a 
“systems-pharmacology” approach is needed [35].
Half-sandwich organometallic complexes provide a rich 
platform for drug design. Their reactivity can be finely con-
trolled by choice of the coordinated ligands. Introduction of 
an azopyridine ligand as an N,N-chelating ligand instead of 
ethylenediamine, for example, can render complexes inert 
and introduce redox mechanisms of action in cancer cells 
[36]. Some transfer hydrogenation catalysts appear to be able 
to carry out NAD+/NADH interconversions in cells [37, 38].
The elements of life: natural selection of the 
elements
Bob was interested in the evolution of life’s chemistry. He 
analysed in detail the chemical speciation of the elements, 
the dynamics of element movement, and dependence on 
the state of the environment [39, 40]. In particular he incor-
porated the fundamental principles of inorganic chemis-
try into his reasoning, for example mineralisation and the 
familiar reactions associated with qualitative analysis (pre-
cipitation of metal sulphides etc.) [41].
Bob coined the term “metallome” so as to emphasise the 
critical role played by the distribution of metal ions in cel-
lular compartments [42]:
“The variety of paths which individual elements fol-
low in any organism adds to the specific character of 
the organism. Clearly the paths have evolved to cre-
ate an element distribution which we shall call the 
metallome” [42].
“The metallome must be recognised as a fundamen-
tal feature of a cellular compartment which is linked 
but not quantitatively to the proteome and the genome 
since it is related also to environmental availabilities 
and to energy supply” [42].
“The chemistry of evolution, according to me, is 
totally dependent on metal ions. You may not want to 
believe that, you may think it is totally dependent on 
DNA, but I believe that’s a thundering mistake” [26].
“There is no doubt therefore that the environment, 
non-metals and metal ions, interact with all the inter-
nal activity of cells, using external energy sources. 
The whole organism can be described as a sum of 
gene units of inheritance, not just DNA” [43]
“Do not forget that the whole environment and organ-
isms are one system” [44]
It is interesting to ask whether the elements we cur-
rently think are essential to man all have recognisable 
DNA codes, i.e. can be linked specifically to a protein that 
handles the element. A summary of current knowledge 
is presented in Table 1 [45]. There is a lot of uncertainty. 
Research on the essentiality of elements is not being pur-
sued so vigorously today as it was 40 years ago. About 20 
elements appear to be essential and most can be linked to 
DNA-coded proteins, but knowledge of how fluorine and 
vanadium are taken up and transported appears to be poor. 
About another six elements are potentially essential with, 
as yet, poor or little evidence of DNA codes.
As an illustration, we discuss briefly the essentiality 
of the halogens. I (PJS) remember Bob emphasising in 
one of his lectures that several oxidation states of chlo-
rine and iodine are important for their biological activ-
ity, not just the simple Cl(−1) and I(−1) ions. His over-
view of the solution-state (thermodynamic, equilibrium) 
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chemistry of the halogens and other elements as por-
trayed by Oxidation State Diagrams (now often called 
Frost Diagrams) was particularly insightful, used to 
great effect in his textbook on Inorganic Chemistry in 
two volumes [46, 47], written jointly with Courtney 
Phillips and widely adopted by Oxford undergradu-
ates. In contrast to the element-by-element or group-
by-group approach of several inorganic other texts, it 
sought to provide an overarching view of the subject in 
a way that could reveal patterns and trends in a readily 
assimilable manner.
The halogens as essential elements
There is no redox chemistry of fluorine in the body, just 
fluoride. Despite the widespread fluoridation of tap water 
with fluoride, which is known to be involved in calcium 
phosphate mineral formation, especially the enamel of 
teeth as fluoroapatite, relatively little is known about the 
biochemistry of fluorine. How is F− transported across 
membranes? Since the pKa of HF is low (ca. 3), it can exist 
in the stomach (where the pH drops to 1.5–3.5) as HF, and 
there appear to be specific HF transport proteins. There also 
appear to be F−/H+ cotransporter and F−/OH− antiporter 
proteins.
Oxidised forms of Cl and I are, in general, strong oxi-
dants, and while they are handled carefully in cells, often 
in membrane-bound compartments so as to avoid damage 
to natural cellular molecules, they are often used to dam-
age toxins (e.g., invading organisms) deliberately within 
the compartment. For example, the abundant white blood 
cells neutrophils ingest pathogenic microorganisms and 
attack them with hypochlorite (bleach) formed from H2O2 
and Cl− by the haem enzyme myeloperoxidase (MPO). 
Activation of phagocytic leukocytes plays a key role in 
the immune response to invading pathogens. MPO can 
also generate HOBr, HOI, and HOSCN, which are also 
Table 1  Essential elements for man (adapted from ref 45)
Atomic number Element Examples of genetic coding
1 H Transmembrane proton pumps
6 C Uptake of organic molecules (amino acids, fatty acids, vitamins etc.), regulation of CO2, carbonate, CO
7 N Pathways for e.g. amino acids, nucleotides, NO synthases; conversion of NH3 into urea
8 O O2 uptake, transport (haemoglobin) and storage (myoglobin), O2-sensor proteins, reduction of O2 to H2O (mitochon-
dria), enzymes for O2
− and H2O2
9 F F(−)/H(+) cotransporter or a F(−)/OH(−) antiporter
11 Na Membrane pumps Na+/K+ ATPase
12 Mg MAGT1, magnesium transporter 1
15 P Kinases, phosphatases, nucleotides
16 S Cys thiol/disulfide and Met in proteins; S2− in ferredoxins
17 Cl Cl− channel: transmembrane conductance regulator (CTFR)
19 K Membrane pumps Na+/K+ ATPase
20 Ca Ca2+-sensor protein troponin; Ca2+-ATPase membrane pump; calmodulin transduces Ca2+ signals in cells
25 Mn Most abundant Mn protein glutamine synthetase; Mn superoxide dismutase in mitochondria
26 Fe Heme and non-heme Fe proteins
27 Co Uptake and carrier proteins for vitamin B12
29 Cu Cu+/Cu2+ proteins ca. 1 % of human proteome
30 Zn Zn2+ proteins ca. 10 % of human proteome
34 Se 25 selenoproteins with redox and signalling functions
42 Mo 4 Mo enzymes (xanthine oxidoreductase and sulphite oxidase families); Mo cofactor
53 I Thyroid hormones
Potentially essential elements
 14 Si Role in bone mineralisation?
 23 V Role in phosphate biochemistry?
 24 Cr Influence on glucose metabolism?
 28 Ni Essential for some microorganisms
Allergenic: MHCII-Ni-peptide recognition by T cells
 35 Br Essential for assembly of collagen IV scaffolds, and killing invading microorganisms as HOBr?
 50 Sn Essential for animal growth?
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involved in the anti-bactericidal activity of neutrophils 
[48].
Bob was interested in the transport of the elements 
across cell membranes, the specificity of the channels and 
pumps, and the creation of gradients. Chloride concen-
tration in body fluids is high (ca. 100 mM in blood) and 
decreases in the cytoplasm (ca. 25 mM) and cell nucleus 
(ca. 4 mM). Epithelial transport of Cl− is mediated by 
the cystic fibrosis transmembrane conductance regulator 
(CTFR) a 1480 amino-acid cAMP-activated ATP-gated 
anion-channel glycoprotein. Mutations in the gene encod-
ing CFTR can cause cystic fibrosis and a type of male ste-
rility as a result of congenital absence of the vas deferens 
[49].
There are significant amounts of bromine in the body 
(ca. 0.2 g), e.g. in blood 3.2–5.6 µg/mL. Until a year ago 
(2014) we would have concluded that bromine is not an 
essential element for man and just noted that sodium bro-
mide is an hypnotic, anticonvulsant, and sedative (Sedoneu-
ral) in medicine. Now it has been suggested that bromine is 
an essential trace element for all animals [50]. Bromide, on 
conversion to HOBr, is required for peroxidasin-catalyzed 
formation of sulfilimine crosslinks in a post-translational 
modification essential for tissue development within the 
collagen IV scaffold of basement membranes. Eosinophils 
(white blood cells) are components of the immune system 
and use eosinophil peroxidase, hydrogen peroxide H2O2, 
and Br− to generate hypobromous acid (HOBr), a potent 
oxidant and part of the host defence against invading para-
sites and eosinophil-mediated tissue damage.
Iodide transport into follicular cells of the thyroid gland, 
the first step in the synthesis of thyroid hormones, involves 
a sodium/iodide symporter (NIS; sodium/iodide cotrans-
porter) that transports two Na+ for each I− into the cell 
[51]. However such transport is not well studied for other 
cell types. Oxidation of iodide by the enzyme thyroid per-
oxidase mediated by H2O2 is an important step for incor-
poration of iodine into thyroglobulin and the production of 
thyroid hormones tetraiodo prohormone thyroxine (T4) and 
triiodothyronine (T3).
Metal isotope selection
Recently, in collaboration with Oxford geologists and oth-
ers, Bob published some insightful papers on metal isotope 
fractionation in living systems.
“Mass fractionation of transition metal isotopes can 
be induced to a considerable level by biological pro-
cesses” [51]
They concluded that organisms incorporate lighter iso-
topes of transition metals (e.g., of Fe and Cu) preferentially, 
and fractionation is controlled by redox processes. The 
implication of these results for the isotopic elemental 
composition of living things on geological timescales is 
thought-provoking.
Bob was inspiring because he was full of ideas and 
never afraid to enter areas of research where he or any-
one else had not been before, especially using cutting-
edge technology with potential for providing insight 
into problems posed by the inorganic chemistry of 
biological systems. Interdisciplinarity was key to his 
thinking, continually crossing the borders of chemistry, 
physics, biology, and medicine. The basis that he has 
established will make bioinorganic chemistry and inor-
ganic biochemistry exciting areas of research for many 
generations to come.
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